SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-24-000007
Filing Date
2024-02-22
Accepted
2024-02-22 16:16:01
Documents
1
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1708636513.html 4  
1 FORM 4 wk-form4_1708636513.xml 4 3676
  Complete submission text file 0001615219-24-000007.txt   5218
Mailing Address 2408 TIMBERLOCH PLACE, B-7 THE WOODLANDS TX 77380
Business Address
Lammers Paul (Reporting) CIK: 0001457289 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 24664997

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)